The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
暂无分享,去创建一个
Michael Thomas | Jan Budczies | Wilko Weichert | Arne Warth | Albrecht Stenzinger | Peter Schirmacher | Thomas Muley | A. Warth | W. Weichert | P. Schirmacher | A. Stenzinger | J. Budczies | Michael Thomas | P. Schnabel | T. Muley | M. Meister | H. Hoffmann | Michael Meister | Hans Hoffmann | Philipp A Schnabel
[1] Zoe Wainer,et al. Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] David Harrington,et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.
[3] Y. Ishikawa,et al. Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor Prognosis , 2003, The American journal of surgical pathology.
[4] F. Hirsch,et al. Systemic therapy of advanced bronchioloalveolar cell carcinoma: challenges and opportunities. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[6] R. Rami-Porta,et al. The New Tumor, Node, and Metastasis Staging System , 2011, Seminars in respiratory and critical care medicine.
[7] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[8] A. Borczuk,et al. Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma , 2009, The American journal of surgical pathology.
[9] Heather N Watson,et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas , 2007, Modern Pathology.
[10] W. Gerald,et al. Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis , 2008, The American journal of surgical pathology.
[11] S. Antoniu. Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease? , 2011, Expert opinion on therapeutic targets.
[12] C. Foucault,et al. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. , 2006, The Annals of thoracic surgery.
[13] Mariano Provencio,et al. Screening for epidermal growth factor receptor mutations in lung cancer. , 2009, The New England journal of medicine.
[14] D. Wigle,et al. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations , 2010, Expert review of respiratory medicine.
[15] Jeffrey W. Clark,et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.
[16] Y. Nishiwaki,et al. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. , 2000, Lung cancer.
[17] Akihiko Yoshizawa,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.
[18] S. Aida,et al. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types , 2004, Histopathology.
[19] Akihiko Yoshizawa,et al. A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors , 2010, The American journal of surgical pathology.
[20] Jungsil Ro,et al. Micropapillary Component in Lung Adenocarcinoma: A Distinctive Histologic Feature With Possible Prognostic Significance , 2002, The American journal of surgical pathology.
[21] Setsuo Hirohashi,et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .
[22] L. Chirieac,et al. Prognostic significance of grading in lung adenocarcinoma , 2010, Cancer.
[23] S S Cross,et al. Grading and scoring in histopathology , 1998, Histopathology.
[24] E. Brambilla,et al. The evolving role of histology in the management of advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.